Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience

Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience

Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract autonomic nervous system dysbalance. Randomized trial...

Full description

Bibliographic Details
Main Authors: Carola Blanco, Tomas Madej, Norman Mangner, Jennifer Hommel, Susanna Grimm, Michael Knaut, Axel Linke, Ephraim B. Winzer
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:ESC Heart Failure
Subjects:
Chronic heart failure
Device therapy
Baroreflex activation therapy
Barostim Neo™
Online Access:https://doi.org/10.1002/ehf2.14508

Internet

https://doi.org/10.1002/ehf2.14508

Similar Items